Companies › CRVS
CORVUS PHARMACEUTICALS INC (CRVS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001626971 · EDGAR filings · Updated 2026-07-27
CORVUS PHARMACEUTICALS INC (CRVS) has reported institutional ownership of 83.3%, with 164 institutional managers holding positions valued at $1.02B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (2)
- 2026-07-27 — SCHEDULE 13G/A filed
- 2026-07-22 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CORVUS PHARMACEUTICALS INC has 164 institutional holders and institutional ownership of 83.3%.
Insider activity
Insiders reported 19 transactions (0 buys, 2 sells) across 5 reporting insiders, with a net reported value of −$9.79M.
Data flags from SEC filings
Related companies
IMMATICS N.V (IMTX) · RECURSION PHARMACEUTICALS IN (RXRX) · CAPRICOR THERAPEUTICS INC (CAPR) · XENCOR INC COM (XNCR) · ARDELYX INC (ARDX) · SMITH & NEPHEW PLC (SNN)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.